UNASSIGNED: Introduction. To determine the efficacy of bipolar transurethral incision with @entity1138 ( @entity1139 ) injection for the treatment of refractory @entity1494 ( @entity1494 ). Materials and Methods. @entity1 who underwent bipolar transurethral incision of @entity1494 (TUIBNS) with @entity1139 injection at our institution from 2013 to 2014 were retrospectively reviewed. A total of 2   mg of 40% @entity1138 solution was injected in four quadrants of the treated @entity1494 . Treatment failure was defined as the need for subsequent intervention. Results. Thirteen @entity1 underwent 17 bipolar TUIBNS with @entity1139 injection. Twelve (92%) @entity1 had failed a mean of 2.2    1.1 prior endoscopic procedures. Median follow-up was 16.5 months (IQR: 14-18.4 months). Initial success was 62%; five (38%) @entity1 had a recurrence with a median time to recurrence of 7.3 months. Four @entity1 underwent a repeat procedure, 2 (50%) of which failed. Overall success was achieved in 77% (10/13) of @entity1 after a mean of 1.3    0.5 procedures. @entity1494 recurrence was not significantly associated with history of pelvic radiation (33% versus 43%, p = 0.9). There were no serious adverse events. Conclusions. Bipolar TUIBNS with @entity1139 injection was comparable in efficacy to previously reported techniques and did not result in any serious adverse events.

Bipolar Transurethral Incision of Bladder Neck Stenoses with XXXX Injection.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1139 :: ('CHEBI:27504', 'Chemical') :: ['MMC'] @entity1138 :: ('MESH:D016685', 'Chemical') :: ['mitomycin C'] @entity1494 :: ('MESH:D001745', 'Disease') :: ['BNS', 'bladder neck stenosis']
@entity1138 :: (MESH:D016685,Chemical) :: ['Mitomycin C']
